The development of general pharmacokinetic model for combined quercetin and metabolites: a low bioavailable compound with high bioavailable metabolites.
Chen Xiao. === "April 2003." === Thesis (Ph.D.)--Chinese University of Hong Kong, 2003. === Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. === Mode of access: World Wide Web.
Other Authors: | Chen, Xiao. |
---|---|
Format: | Others |
Language: | English Chinese |
Published: |
2003
|
Subjects: | |
Online Access: | http://library.cuhk.edu.hk/record=b6073572 http://repository.lib.cuhk.edu.hk/en/item/cuhk-343353 |
Similar Items
-
The contribution of absorption of integral nanocrystals to enhancement of oral bioavailability of quercetin
by: Baode Shen, et al.
Published: (2021-04-01) -
Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals
by: Fakhrossadat Emami, et al.
Published: (2018-08-01) -
Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions
by: Haowen Li, et al.
Published: (2021-01-01) -
QUERCETIN PHYSICAL-CHEMICAL CHARACTERISTICS’ DEFINITION
by: I. V. Kovalevska
Published: (2014-04-01) -
Comparative Pharmacokinetic and Bioavailability Studies of Monotropein, Kaempferol, 3-O-Glucoside and Quercetin 4'-O-Glucoside after Oral and Intravenous Administration of Motilperm in Rats
by: Bo Ram Choi, et al.
Published: (2020-07-01)